Dyne Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2021 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Dyne Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2021 to Q4 2023.
Dyne Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending December 31, 2023 was $5.36M, a 23.7% decline year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$5.36M	-$1.67M	-23.7%	Dec 31, 2023	10-K	2024-03-05
Q4 2022	$7.02M	-$1.83M	-20.7%	Dec 31, 2022	10-K	2023-03-02
Q4 2021	$8.85M			Dec 31, 2021	10-K	2022-03-10
Q3 2021	$9.32M			Sep 30, 2021	10-Q	2021-11-04
Q2 2021	$3K^*			Jun 30, 2021	10-Q	2021-08-05
Q1 2021	$7M			Mar 31, 2021	10-Q	2021-05-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.